Eli Lilly and Company · 1 day ago
Sr Director, ExploR&D Clinical Operations West Coast
US, San Francisco CA
Full-time
Hybrid
Director/Executive
$156K/yr - $229K/yr
8+ years expEli Lilly and Company is a global healthcare leader headquartered in Indianapolis, Indiana. The Senior Director, ExploR&D Clinical Operations West Coast role serves as the clinical technical lead and strategic partner for cross-functional teams, focusing on enhancing efficiency and innovation in clinical plans and trial designs across the ExploR&D external pipeline.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Act as technical clinical operations leader on due diligence assessments for external assets, evaluating potential fit for Lilly clinical partnership
Develop and execute integrated clinical operations plans and strategies designed through feasibility assessments for early phase assets, from first in human studies through clinical proof of concept
Drive operational excellence and innovation in partnered asset plans by influencing key decisions on study design, geographic strategies, site selection, CRO partnerships, and PSM rates to optimize efficiency and delivery
Provide clinical technical expertise to the clinical operations team to assess clinical study progress, develop mitigation action plans, and resolve barriers to meeting committed milestone dates
Serve as the escalation point and expert resource for the China ExploR&D team and China biotech sponsors, providing hands-on clinical operations support to resolve sophisticated challenges, rescue underperforming studies, and implement corrective action plans for trials not meeting enrollment, quality, or timeline expectations in China and Asia-PAC regions
Lead development and implementation of ExploR&D Clinical SOPs and corresponding checklists, ensuring appropriate linkages to Lilly Standards
Champion adoption of new Lilly and ExploR&D clinical capabilities to enhance portfolio delivery and operational efficiency
Recruit, manage, develop, and mentor clinical operations personnel, fostering a high-performance culture and building organizational capability
Qualification
Required
Bachelor's degree (preference in a science field) from an accredited college or university
8+ years work experience directly managing clinical studies with emphasis on early phase and outsourced trials
2+ years of experience implementing clinical trials in China
Fluent in Mandarin (Written and Speaking)
Preferred
Advanced degrees and/or additional degrees in finance, accounting, legal, or MBA preferred
Strong leadership abilities, strategic thinking, and entrepreneurial mindset
Demonstrated success in clinical planning development and clinical feasibility assessments
Proven track record troubleshooting and recovering challenged clinical trials, with ability to quickly assess root causes and implement effective corrective actions
Strong cross-cultural communication and influence skills with experience navigating complex stakeholder environments across geographies
Benefits
Company bonus
401(k)
Pension
Vacation benefits
Medical, dental, vision and prescription drug benefits
Flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts)
Life insurance and death benefits
Certain time off and leave of absence benefits
Well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities)
Company
Eli Lilly and Company
We're a medicine company turning science into healing to make life better for people around the world.
10001+ employees
H1B Sponsorship
Eli Lilly and Company has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (514)
2024 (236)
2023 (167)
2022 (133)
2021 (57)
2020 (52)
Funding
Current Stage
Public CompanyTotal Funding
$6.5M2024-02-12Post Ipo Debt· $6.5M
1978-01-13IPO
Leadership Team
David Ricks
Chair, CEO
Lucas Montarce
Executive Vice President and Chief Financial Officer
Recent News
Company data provided by crunchbase